The Affordable Care Act, Part Two: Prescription Drug Prices, Medicare Part D and Billy Tauzin

This is the second of two blog posts which discuss the role that corporate influence and campaign contributions played in the development and passage of the Patient Protection and Affordable Care Act, also known as Obamacare. This post discusses the influence of the pharmaceutical industry in shaping federal legislation, including the PPACA, to prevent the … Continue reading